Hyperscale Data details Alzamend Neuro warrant stakes
Hyperscale Data, Inc., whose Executive Chairman is Milton C. Ault III, reports indirect ownership in Alzamend Neuro through its wholly owned subsidiary Ault Lending.
Rhea-AI Filing Summary
Hyperscale Data, Inc., whose Executive Chairman is Milton C. Ault III, reports indirect ownership in Alzamend Neuro through its wholly owned subsidiary Ault Lending. It lists common stock purchase warrants exercisable into 494.0000, 988.0000, 13556.0000, 8667.0000 and 1111.0000 common shares at exercise prices of 4050.0000 and 108.0000, with expirations between 2026 and 2029. HSD and related entities are treated as directors by deputization for Section 16 purposes.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Hyperscale Data, Inc.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock Purchase Warrants F1 | -- | -- | -- |
| holding | Common Stock Purchase Warrants F1 | -- | -- | -- |
| holding | Common Stock Purchase Warrants F1 | -- | -- | -- |
| holding | Common Stock Purchase Warrants F1 | -- | -- | -- |
| holding | Common Stock Purchase Warrants F1 | -- | -- | -- |
Holdings After Transaction:
Common Stock Purchase Warrants — 24,816 contracts (Indirect, By Ault Lending, LLC)
Footnotes (1)
- F1. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Capital Group, Inc. ("ACG"). ACG is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Milton C. Ault, III, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
Key Figures
Underlying shares (warrants, series 1): 494.0000
Underlying shares (warrants, series 2): 988.0000
Underlying shares (warrants, series 3): 13556.0000
+4 more
7 metrics
Underlying shares (warrants, series 1)
494.0000
Common stock underlying warrants with 4050.0000 exercise price expiring 2026-07-30
Underlying shares (warrants, series 2)
988.0000
Common stock underlying warrants with 4050.0000 exercise price expiring 2027-04-26
Underlying shares (warrants, series 3)
13556.0000
Common stock underlying warrants with 108.0000 exercise price expiring 2029-08-01
Underlying shares (warrants, series 4)
8667.0000
Common stock underlying warrants with 108.0000 exercise price expiring 2029-09-27
Underlying shares (warrants, series 5)
1111.0000
Common stock underlying warrants with 108.0000 exercise price expiring 2029-10-30
Warrant exercise price (high)
4050.0000
Exercise price for two warrant series on Alzamend Neuro common stock
Warrant exercise price (low)
108.0000
Exercise price for three warrant series on Alzamend Neuro common stock
Key Terms
director by deputization, Section 16 of the Exchange Act, Common Stock Purchase Warrants, voting and investment power
4 terms
director by deputization regulatory
"may be deemed a director by deputization by virtue of their representation"
Section 16 of the Exchange Act regulatory
"For purposes of Section 16 of the Exchange Act, each of HSD, ACG and"
Common Stock Purchase Warrants financial
"security_title: Common Stock Purchase Warrants with underlying Common Stock"
Common stock purchase warrants are tradable instruments that give the holder the right to buy a company’s common shares at a set price before a specified date, like a coupon that lets you purchase stock later at a fixed rate. They matter to investors because they offer a way to gain future upside if the stock rises, but when exercised they increase the number of shares outstanding and can reduce existing shareholders’ ownership and earnings per share.
voting and investment power financial
"is deemed to have voting and investment power with respect to the securities"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider position does Hyperscale Data report in ALZN?
Hyperscale Data reports indirect ownership of Alzamend Neuro via its wholly owned subsidiary Ault Lending. The position consists of common stock purchase warrants linked to multiple blocks of underlying ALZN common shares rather than direct stock ownership.
What are the exercise prices of Hyperscale Data’s ALZN warrants?
The warrants reported for ALZN have exercise prices of 4050.0000 and 108.0000. Each price applies to specific warrant series, defining the amount payable per share of underlying common stock if Ault Lending chooses to exercise them.
When do the reported ALZN warrants held by Hyperscale Data expire?
The common stock purchase warrants on ALZN common shares expire between 2026 and 2029, with stated expiration dates of 2026-07-30, 2027-04-26, 2029-08-01, 2029-09-27 and 2029-10-30. These dates define the final exercise windows for each warrant series.
How is Milton C. Ault III connected to Hyperscale Data’s ALZN holdings?
Milton C. Ault III is described as the Executive Chairman of Hyperscale Data and is deemed to have voting and investment power over securities held of record by Ault Lending, the subsidiary through which the ALZN warrants are held.
What does “director by deputization” mean in this ALZN disclosure?
Hyperscale Data and its affiliates HSD, ACG and Ault Lending may be deemed directors by deputization under Section 16 due to their representation on Alzamend Neuro’s Board. This status makes them reporting persons for the company’s equity securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
